
Zencore Biologics
臻格生物
Zencore Biologics
Biotech/Healthcare
Founded in 2017, Shanghai ZhenGe Biotech provides CDMO services for large-molecule biologics and develops and manufactures mammalian cell culture media. Its services include developability assessments for biologics, cell line development, process development and optimization, preclinical…
Latest round: Series C Extension (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-08-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.